Stockreport

Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout [Yahoo! Finance Canada]

Catalent, Inc.  (CTLT) 
Last catalent, inc. earnings: 2/3 07:30 am Check Earnings Report
US:NYSE Investor Relations: investor.catalent.com
PDF Catalent will operate as an independent contract drugmaker even after the acquisition, Maselli reiterated, adding that he wanted to "correct a few key inaccuracies that [Read more]